Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
CANO.WS was delisted on the 9th of November, 2023.
35 hedge funds and large institutions have $43.6M invested in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in 2021 Q2 according to their latest regulatory filings, with 35 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
+$10.9M |
| 2 |
LCM
LH Capital Markets
New York
|
+$5.76M |
| 3 |
LA
Linden Advisors
New York
|
+$5.6M |
| 4 |
BlackRock
New York
|
+$5.22M |
| 5 |
GL
Governors Lane
New York
|
+$3.38M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SC
26
Shay Capital
New York
| $117K | +$144K | +31,800 | New |
|
|
DCM
27
Dupont Capital Management
Wilmington,
Delaware
| $92K | +$113K | +25,000 | New |
|
|
MP
28
MSD Partners
New York
| $92K | +$113K | +25,000 | New |
|
|
NRCM
29
Northern Right Capital Management
Darien,
Connecticut
| $59K | +$72.1K | +15,958 | New |
|
|
VF
30
Virtu Financial
New York
| $55K | +$67.1K | +14,857 | New |
|
31
Jane Street
New York
| $38K | +$46.6K | +10,330 | New |
|
32
Morgan Stanley
New York
| $22K | +$27K | +5,989 | New |
|
33
Wells Fargo
San Francisco,
California
| $1K | +$1.8K | +399 | New |
|
34
Walleye Capital
New York
| $759 | +$929K | +205,704 | New |
|
|
TFS
35
TrustCore Financial Services
Brentwood,
Tennessee
| – | +$452 | +100 | New |
|
|
TRCT
36
Tower Research Capital (TRC)
New York
| – | +$470 | +104 | New |
|
CANO.WS Hedge Fund Activity: Q2 2021 in Review
35 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) for Q2 2021, worth a combined $43.6M.
Buyers outnumbered sellers: 35 funds opened new CANO.WS positions and 0 closed out — a net gain of 35 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Ionic Capital Management, opening a new position worth an estimated $10.9M.
- 35 institutional investors held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $43.6M of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 stock for Q2 2021.
- 35 funds opened new Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 positions in Q2 2021 and 0 closed out, a net change of +35 holders.
- The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 buyer in Q2 2021 was Ionic Capital Management, an estimated $10.9M added.
Based on aggregated 13F filings for Q2 2021.